img

Global Crohn's Disease Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Crohn's Disease Market Research Report 2024

Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large and small intestine and is generally diagnosed in persons within the age group of 20-29. It can have severe or acute outcomes. Signs and symptoms of Crohn’s disease develop slowly and gradually. Some of the common symptoms of this disease include abdominal pain and cramping, fever, fatigue, diarrhea, blood in stools, appetite and weight loss. Inflammation of skin, joints, and eyes, inflammation of the liver or bile duct, and delayed sexual development in children are some other symptoms associated with severe Crohn’s disease.
According to MRAResearch’s new survey, global Crohn's Disease market is projected to reach US$ 11030 million in 2033, increasing from US$ 8655.3 million in 2022, with the CAGR of 3.1% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Crohn's Disease market research.
Rising number of drug therapies for Crohn’s disease and increasing demand for better diagnostics and treatment options for the auto-immune disease are some of the key factors driving the growth of the global Crohn’s disease market. In addition, rise in the number of patients suffering from auto-immune disorders in developing countries and increasing government initiatives for improving health care infrastructure are fueling the growth of the global Crohn’s disease market. However, less awareness among people about the disease is also restraining the growth of the market. Patent expiry of various useful drugs, such as remicade and humira, is also impeding the growth of the market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Crohn's Disease market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbvie
Amgen
Cambridge Antibody Technology
Janssen Biotech
Pfizer
Tillotts Pharma
Johnson & Johnson
Boehringer Ingelheim
Segment by Type
Surgery
Drug Therapy

Segment by Application


Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Crohn's Disease report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn's Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Surgery
1.2.3 Drug Therapy
1.3 Market by Application
1.3.1 Global Crohn's Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn's Disease Market Perspective (2018-2033)
2.2 Crohn's Disease Growth Trends by Region
2.2.1 Global Crohn's Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Crohn's Disease Historic Market Size by Region (2018-2023)
2.2.3 Crohn's Disease Forecasted Market Size by Region (2024-2033)
2.3 Crohn's Disease Market Dynamics
2.3.1 Crohn's Disease Industry Trends
2.3.2 Crohn's Disease Market Drivers
2.3.3 Crohn's Disease Market Challenges
2.3.4 Crohn's Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn's Disease Players by Revenue
3.1.1 Global Top Crohn's Disease Players by Revenue (2018-2023)
3.1.2 Global Crohn's Disease Revenue Market Share by Players (2018-2023)
3.2 Global Crohn's Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Crohn's Disease Revenue
3.4 Global Crohn's Disease Market Concentration Ratio
3.4.1 Global Crohn's Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn's Disease Revenue in 2022
3.5 Crohn's Disease Key Players Head office and Area Served
3.6 Key Players Crohn's Disease Product Solution and Service
3.7 Date of Enter into Crohn's Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn's Disease Breakdown Data by Type
4.1 Global Crohn's Disease Historic Market Size by Type (2018-2023)
4.2 Global Crohn's Disease Forecasted Market Size by Type (2024-2033)
5 Crohn's Disease Breakdown Data by Application
5.1 Global Crohn's Disease Historic Market Size by Application (2018-2023)
5.2 Global Crohn's Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Crohn's Disease Market Size (2018-2033)
6.2 North America Crohn's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Crohn's Disease Market Size by Country (2018-2023)
6.4 North America Crohn's Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn's Disease Market Size (2018-2033)
7.2 Europe Crohn's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Crohn's Disease Market Size by Country (2018-2023)
7.4 Europe Crohn's Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn's Disease Market Size (2018-2033)
8.2 Asia-Pacific Crohn's Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Crohn's Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Crohn's Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn's Disease Market Size (2018-2033)
9.2 Latin America Crohn's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Crohn's Disease Market Size by Country (2018-2023)
9.4 Latin America Crohn's Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn's Disease Market Size (2018-2033)
10.2 Middle East & Africa Crohn's Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Crohn's Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Crohn's Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Detail
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Crohn's Disease Introduction
11.1.4 Abbvie Revenue in Crohn's Disease Business (2018-2023)
11.1.5 Abbvie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Crohn's Disease Introduction
11.2.4 Amgen Revenue in Crohn's Disease Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 Cambridge Antibody Technology
11.3.1 Cambridge Antibody Technology Company Detail
11.3.2 Cambridge Antibody Technology Business Overview
11.3.3 Cambridge Antibody Technology Crohn's Disease Introduction
11.3.4 Cambridge Antibody Technology Revenue in Crohn's Disease Business (2018-2023)
11.3.5 Cambridge Antibody Technology Recent Development
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Detail
11.4.2 Janssen Biotech Business Overview
11.4.3 Janssen Biotech Crohn's Disease Introduction
11.4.4 Janssen Biotech Revenue in Crohn's Disease Business (2018-2023)
11.4.5 Janssen Biotech Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Crohn's Disease Introduction
11.5.4 Pfizer Revenue in Crohn's Disease Business (2018-2023)
11.5.5 Pfizer Recent Development
11.6 Tillotts Pharma
11.6.1 Tillotts Pharma Company Detail
11.6.2 Tillotts Pharma Business Overview
11.6.3 Tillotts Pharma Crohn's Disease Introduction
11.6.4 Tillotts Pharma Revenue in Crohn's Disease Business (2018-2023)
11.6.5 Tillotts Pharma Recent Development
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Detail
11.7.2 Johnson & Johnson Business Overview
11.7.3 Johnson & Johnson Crohn's Disease Introduction
11.7.4 Johnson & Johnson Revenue in Crohn's Disease Business (2018-2023)
11.7.5 Johnson & Johnson Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Crohn's Disease Introduction
11.8.4 Boehringer Ingelheim Revenue in Crohn's Disease Business (2018-2023)
11.8.5 Boehringer Ingelheim Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Crohn's Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Surgery
Table 3. Key Players of Drug Therapy
Table 4. Global Crohn's Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Crohn's Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Crohn's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Crohn's Disease Market Share by Region (2018-2023)
Table 8. Global Crohn's Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Crohn's Disease Market Share by Region (2024-2033)
Table 10. Crohn's Disease Market Trends
Table 11. Crohn's Disease Market Drivers
Table 12. Crohn's Disease Market Challenges
Table 13. Crohn's Disease Market Restraints
Table 14. Global Crohn's Disease Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Crohn's Disease Market Share by Players (2018-2023)
Table 16. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn's Disease as of 2022)
Table 17. Ranking of Global Top Crohn's Disease Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Crohn's Disease Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Crohn's Disease Product Solution and Service
Table 21. Date of Enter into Crohn's Disease Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn's Disease Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Crohn's Disease Revenue Market Share by Type (2018-2023)
Table 25. Global Crohn's Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Crohn's Disease Revenue Market Share by Type (2024-2033)
Table 27. Global Crohn's Disease Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Crohn's Disease Revenue Market Share by Application (2018-2023)
Table 29. Global Crohn's Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Crohn's Disease Revenue Market Share by Application (2024-2033)
Table 31. North America Crohn's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Crohn's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Crohn's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Crohn's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Crohn's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Crohn's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Crohn's Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Crohn's Disease Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Crohn's Disease Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Crohn's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Crohn's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Crohn's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Crohn's Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Crohn's Disease Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Crohn's Disease Market Size by Country (2024-2033) & (US$ Million)
Table 46. Abbvie Company Detail
Table 47. Abbvie Business Overview
Table 48. Abbvie Crohn's Disease Product
Table 49. Abbvie Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 50. Abbvie Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Crohn's Disease Product
Table 54. Amgen Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Cambridge Antibody Technology Company Detail
Table 57. Cambridge Antibody Technology Business Overview
Table 58. Cambridge Antibody Technology Crohn's Disease Product
Table 59. Cambridge Antibody Technology Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 60. Cambridge Antibody Technology Recent Development
Table 61. Janssen Biotech Company Detail
Table 62. Janssen Biotech Business Overview
Table 63. Janssen Biotech Crohn's Disease Product
Table 64. Janssen Biotech Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 65. Janssen Biotech Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Crohn's Disease Product
Table 69. Pfizer Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Tillotts Pharma Company Detail
Table 72. Tillotts Pharma Business Overview
Table 73. Tillotts Pharma Crohn's Disease Product
Table 74. Tillotts Pharma Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 75. Tillotts Pharma Recent Development
Table 76. Johnson & Johnson Company Detail
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Crohn's Disease Product
Table 79. Johnson & Johnson Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. Boehringer Ingelheim Company Detail
Table 82. Boehringer Ingelheim Business Overview
Table 83. Boehringer Ingelheim Crohn's Disease Product
Table 84. Boehringer Ingelheim Revenue in Crohn's Disease Business (2018-2023) & (US$ Million)
Table 85. Boehringer Ingelheim Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Crohn's Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Crohn's Disease Market Share by Type: 2022 VS 2033
Figure 3. Surgery Features
Figure 4. Drug Therapy Features
Figure 5. Global Crohn's Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Crohn's Disease Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Crohn's Disease Report Years Considered
Figure 11. Global Crohn's Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Crohn's Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Crohn's Disease Market Share by Region: 2022 VS 2033
Figure 14. Global Crohn's Disease Market Share by Players in 2022
Figure 15. Global Top Crohn's Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn's Disease as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Crohn's Disease Revenue in 2022
Figure 17. North America Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Crohn's Disease Market Share by Country (2018-2033)
Figure 19. United States Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Crohn's Disease Market Share by Country (2018-2033)
Figure 23. Germany Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Crohn's Disease Market Share by Region (2018-2033)
Figure 31. China Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Crohn's Disease Market Share by Country (2018-2033)
Figure 39. Mexico Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Crohn's Disease Market Share by Country (2018-2033)
Figure 43. Turkey Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Crohn's Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Abbvie Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 46. Amgen Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 47. Cambridge Antibody Technology Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 48. Janssen Biotech Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 50. Tillotts Pharma Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 51. Johnson & Johnson Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Crohn's Disease Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed